Animal coronavirus vaccines : Lessons for SARS
Identifieur interne : 005B77 ( Main/Exploration ); précédent : 005B76; suivant : 005B78Animal coronavirus vaccines : Lessons for SARS
Auteurs : L. J. Saif [États-Unis]Source :
- Developments in biologicals [ 1424-6074 ] ; 2004.
Descripteurs français
- KwdFr :
- Animaux, Humains, Infections à coronavirus (), Infections à coronavirus (médecine vétérinaire), Infections à coronavirus (transmission), Infections à coronavirus (épidémiologie), Réservoirs d'agents pathogènes (médecine vétérinaire), Santé publique, Spécificité d'espèce, Syndrome respiratoire aigu sévère (), Syndrome respiratoire aigu sévère (transmission), Syndrome respiratoire aigu sévère (épidémiologie), Vaccination (médecine vétérinaire), Vaccins antiviraux (immunologie), Vaccins atténués, Virus du SRAS (immunologie), Zoonoses.
- MESH :
- immunologie : Vaccins antiviraux, Virus du SRAS.
- médecine vétérinaire : Infections à coronavirus, Réservoirs d'agents pathogènes, Vaccination.
- épidémiologie : Infections à coronavirus, Syndrome respiratoire aigu sévère.
- Pascal (Inist)
- Animaux, Humains, Infections à coronavirus, Santé publique, Spécificité d'espèce, Syndrome respiratoire aigu sévère, Vaccins atténués, Virus syndrome respiratoire aigu sévère, Homme, Porcin, Vaccin, Chine, Origine, Transmission, Réservoir, Santé publique, Muqueuse, Immunité locale, Syndrome respiratoire aigu sévère, Maladie émergente, Adjuvant immunologique, Complication, Echec, Article synthèse, Zoonoses.
- Wicri :
- topic : Homme, Porcin, Vaccin, Santé publique.
English descriptors
- KwdEn :
- Animals, China, Complication, Coronavirus Infections (epidemiology), Coronavirus Infections (prevention & control), Coronavirus Infections (transmission), Coronavirus Infections (veterinary), Disease Reservoirs (veterinary), Emerging disease, Failure, Human, Humans, Immunological adjuvant, Local immunity, Mucosa, Origin, Public Health, Public health, Reservoir, Review, SARS Virus (immunology), Severe Acute Respiratory Syndrome (epidemiology), Severe Acute Respiratory Syndrome (prevention & control), Severe Acute Respiratory Syndrome (transmission), Severe acute respiratory syndrome, Severe acute respiratory syndrome virus, Species Specificity, Swine, Transmission, Vaccination (veterinary), Vaccine, Vaccines, Attenuated, Viral Vaccines (immunology), Zoonoses.
- MESH :
- chemical , immunology : Viral Vaccines.
- chemical : Vaccines, Attenuated.
- epidemiology : Coronavirus Infections, Severe Acute Respiratory Syndrome.
- immunology : SARS Virus.
- prevention & control : Coronavirus Infections, Severe Acute Respiratory Syndrome.
- transmission : Coronavirus Infections, Severe Acute Respiratory Syndrome.
- veterinary : Coronavirus Infections, Disease Reservoirs, Vaccination.
- Animals, Humans, Public Health, Species Specificity, Zoonoses.
Abstract
Severe acute respiratory syndrome (SARS) emerged in China and spread globally as a human pandemic. It is caused by a new coronavirus (CoV) of suspect animal origin. The emergence of SARS stunned medical scientists, but veterinary virologists had previously recognized CoVs as causing fatal respiratory or enteric disease in animals with interspecies transmission and wildlife reservoirs. Because of its public health impact, major efforts are focused on development of SARS vaccines. Occurrence of CoV disease at mucosal surfaces necessitates the stimulation of local immunity, having an impact on the vaccine type, delivery and adjuvant needed to achieve mucosal immunity. Such immunity is often short-lived, requires frequent boosting and may not prevent re-infection, all factors complicating CoV vaccine design. SARS vaccine efforts should be enhanced by understanding the correlates of protection and reasons for the success or failure of animal CoV vaccines. This review will focus on studies of immunity and protection in swine to the enteric CoV, transmissible gastroenteritis (TGEV) versus the respiratory variant, porcine respiratory CoV (PRCV), comparing live, inactivated and subunit vaccines, various vaccine vectors, routes and adjuvants. In addition avian infectious bronchitis CoV (IBV) vaccines targeted for protection of the upper respiratory tract of chickens are discussed. Unfortunately, despite long-term efforts, effective vaccines to prevent enteric CoV infections remain elusive, and generally live, but not killed vaccines, have induced the most consistent protection against animal CoVs. Confirmation of the pathogenesis of SARS in humans or animals models that mimic SARS may further aid in vaccine design and evaluation.
Affiliations:
Links toward previous steps (curation, corpus...)
- to stream PascalFrancis, to step Corpus: 000713
- to stream PascalFrancis, to step Curation: 000277
- to stream PascalFrancis, to step Checkpoint: 000894
- to stream Main, to step Merge: 006045
- to stream PubMed, to step Corpus: 002865
- to stream PubMed, to step Curation: 002865
- to stream PubMed, to step Checkpoint: 002E35
- to stream Ncbi, to step Merge: 000E07
- to stream Ncbi, to step Curation: 000E07
- to stream Ncbi, to step Checkpoint: 000E07
- to stream Main, to step Merge: 005910
- to stream Main, to step Curation: 005B77
Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en" level="a">Animal coronavirus vaccines : Lessons for SARS</title><author><name sortKey="Saif, L J" sort="Saif, L J" uniqKey="Saif L" first="L. J." last="Saif">L. J. Saif</name><affiliation wicri:level="2"><inist:fA14 i1="01"><s1>Food Animal Health Research Program, OARDC, The Ohio State University</s1><s2>Wooster, OH</s2><s3>USA</s3><sZ>1 aut.</sZ></inist:fA14><country>États-Unis</country><placeName><region type="state">Ohio</region></placeName></affiliation></author></titleStmt><publicationStmt><idno type="wicri:source">INIST</idno><idno type="inist">05-0154089</idno><date when="2004">2004</date><idno type="stanalyst">PASCAL 05-0154089 INIST</idno><idno type="RBID">Pascal:05-0154089</idno><idno type="wicri:Area/PascalFrancis/Corpus">000713</idno><idno type="wicri:Area/PascalFrancis/Curation">000277</idno><idno type="wicri:Area/PascalFrancis/Checkpoint">000894</idno><idno type="wicri:explorRef" wicri:stream="PascalFrancis" wicri:step="Checkpoint">000894</idno><idno type="wicri:doubleKey">1424-6074:2004:Saif L:animal:coronavirus:vaccines</idno><idno type="wicri:Area/Main/Merge">006045</idno><idno type="wicri:source">PubMed</idno><idno type="RBID">pubmed:15742624</idno><idno type="wicri:Area/PubMed/Corpus">002865</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">002865</idno><idno type="wicri:Area/PubMed/Curation">002865</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">002865</idno><idno type="wicri:Area/PubMed/Checkpoint">002E35</idno><idno type="wicri:explorRef" wicri:stream="Checkpoint" wicri:step="PubMed">002E35</idno><idno type="wicri:Area/Ncbi/Merge">000E07</idno><idno type="wicri:Area/Ncbi/Curation">000E07</idno><idno type="wicri:Area/Ncbi/Checkpoint">000E07</idno><idno type="wicri:doubleKey">1424-6074:2004:Saif L:animal:coronavirus:vaccines</idno><idno type="wicri:Area/Main/Merge">005910</idno><idno type="wicri:Area/Main/Curation">005B77</idno><idno type="wicri:Area/Main/Exploration">005B77</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en" level="a">Animal coronavirus vaccines : Lessons for SARS</title><author><name sortKey="Saif, L J" sort="Saif, L J" uniqKey="Saif L" first="L. J." last="Saif">L. J. Saif</name><affiliation wicri:level="2"><inist:fA14 i1="01"><s1>Food Animal Health Research Program, OARDC, The Ohio State University</s1><s2>Wooster, OH</s2><s3>USA</s3><sZ>1 aut.</sZ></inist:fA14><country>États-Unis</country><placeName><region type="state">Ohio</region></placeName></affiliation></author></analytic><series><title level="j" type="main">Developments in biologicals</title><title level="j" type="abbreviated">Dev. biol.</title><idno type="ISSN">1424-6074</idno><imprint><date when="2004">2004</date></imprint></series></biblStruct></sourceDesc><seriesStmt><title level="j" type="main">Developments in biologicals</title><title level="j" type="abbreviated">Dev. biol.</title><idno type="ISSN">1424-6074</idno></seriesStmt></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Animals</term><term>China</term><term>Complication</term><term>Coronavirus Infections (epidemiology)</term><term>Coronavirus Infections (prevention & control)</term><term>Coronavirus Infections (transmission)</term><term>Coronavirus Infections (veterinary)</term><term>Disease Reservoirs (veterinary)</term><term>Emerging disease</term><term>Failure</term><term>Human</term><term>Humans</term><term>Immunological adjuvant</term><term>Local immunity</term><term>Mucosa</term><term>Origin</term><term>Public Health</term><term>Public health</term><term>Reservoir</term><term>Review</term><term>SARS Virus (immunology)</term><term>Severe Acute Respiratory Syndrome (epidemiology)</term><term>Severe Acute Respiratory Syndrome (prevention & control)</term><term>Severe Acute Respiratory Syndrome (transmission)</term><term>Severe acute respiratory syndrome</term><term>Severe acute respiratory syndrome virus</term><term>Species Specificity</term><term>Swine</term><term>Transmission</term><term>Vaccination (veterinary)</term><term>Vaccine</term><term>Vaccines, Attenuated</term><term>Viral Vaccines (immunology)</term><term>Zoonoses</term></keywords><keywords scheme="KwdFr" xml:lang="fr"><term>Animaux</term><term>Humains</term><term>Infections à coronavirus ()</term><term>Infections à coronavirus (médecine vétérinaire)</term><term>Infections à coronavirus (transmission)</term><term>Infections à coronavirus (épidémiologie)</term><term>Réservoirs d'agents pathogènes (médecine vétérinaire)</term><term>Santé publique</term><term>Spécificité d'espèce</term><term>Syndrome respiratoire aigu sévère ()</term><term>Syndrome respiratoire aigu sévère (transmission)</term><term>Syndrome respiratoire aigu sévère (épidémiologie)</term><term>Vaccination (médecine vétérinaire)</term><term>Vaccins antiviraux (immunologie)</term><term>Vaccins atténués</term><term>Virus du SRAS (immunologie)</term><term>Zoonoses</term></keywords><keywords scheme="MESH" type="chemical" qualifier="immunology" xml:lang="en"><term>Viral Vaccines</term></keywords><keywords scheme="MESH" type="chemical" xml:lang="en"><term>Vaccines, Attenuated</term></keywords><keywords scheme="MESH" qualifier="epidemiology" xml:lang="en"><term>Coronavirus Infections</term><term>Severe Acute Respiratory Syndrome</term></keywords><keywords scheme="MESH" qualifier="immunologie" xml:lang="fr"><term>Vaccins antiviraux</term><term>Virus du SRAS</term></keywords><keywords scheme="MESH" qualifier="immunology" xml:lang="en"><term>SARS Virus</term></keywords><keywords scheme="MESH" qualifier="médecine vétérinaire" xml:lang="fr"><term>Infections à coronavirus</term><term>Réservoirs d'agents pathogènes</term><term>Vaccination</term></keywords><keywords scheme="MESH" qualifier="prevention & control" xml:lang="en"><term>Coronavirus Infections</term><term>Severe Acute Respiratory Syndrome</term></keywords><keywords scheme="MESH" qualifier="transmission" xml:lang="en"><term>Coronavirus Infections</term><term>Severe Acute Respiratory Syndrome</term></keywords><keywords scheme="MESH" qualifier="veterinary" xml:lang="en"><term>Coronavirus Infections</term><term>Disease Reservoirs</term><term>Vaccination</term></keywords><keywords scheme="MESH" qualifier="épidémiologie" xml:lang="fr"><term>Infections à coronavirus</term><term>Syndrome respiratoire aigu sévère</term></keywords><keywords scheme="MESH" xml:lang="en"><term>Animals</term><term>Humans</term><term>Public Health</term><term>Species Specificity</term><term>Zoonoses</term></keywords><keywords scheme="Pascal" xml:lang="fr"><term>Animaux</term><term>Humains</term><term>Infections à coronavirus</term><term>Santé publique</term><term>Spécificité d'espèce</term><term>Syndrome respiratoire aigu sévère</term><term>Vaccins atténués</term><term>Virus syndrome respiratoire aigu sévère</term><term>Homme</term><term>Porcin</term><term>Vaccin</term><term>Chine</term><term>Origine</term><term>Transmission</term><term>Réservoir</term><term>Santé publique</term><term>Muqueuse</term><term>Immunité locale</term><term>Syndrome respiratoire aigu sévère</term><term>Maladie émergente</term><term>Adjuvant immunologique</term><term>Complication</term><term>Echec</term><term>Article synthèse</term><term>Zoonoses</term></keywords><keywords scheme="Wicri" type="topic" xml:lang="fr"><term>Homme</term><term>Porcin</term><term>Vaccin</term><term>Santé publique</term></keywords></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">Severe acute respiratory syndrome (SARS) emerged in China and spread globally as a human pandemic. It is caused by a new coronavirus (CoV) of suspect animal origin. The emergence of SARS stunned medical scientists, but veterinary virologists had previously recognized CoVs as causing fatal respiratory or enteric disease in animals with interspecies transmission and wildlife reservoirs. Because of its public health impact, major efforts are focused on development of SARS vaccines. Occurrence of CoV disease at mucosal surfaces necessitates the stimulation of local immunity, having an impact on the vaccine type, delivery and adjuvant needed to achieve mucosal immunity. Such immunity is often short-lived, requires frequent boosting and may not prevent re-infection, all factors complicating CoV vaccine design. SARS vaccine efforts should be enhanced by understanding the correlates of protection and reasons for the success or failure of animal CoV vaccines. This review will focus on studies of immunity and protection in swine to the enteric CoV, transmissible gastroenteritis (TGEV) versus the respiratory variant, porcine respiratory CoV (PRCV), comparing live, inactivated and subunit vaccines, various vaccine vectors, routes and adjuvants. In addition avian infectious bronchitis CoV (IBV) vaccines targeted for protection of the upper respiratory tract of chickens are discussed. Unfortunately, despite long-term efforts, effective vaccines to prevent enteric CoV infections remain elusive, and generally live, but not killed vaccines, have induced the most consistent protection against animal CoVs. Confirmation of the pathogenesis of SARS in humans or animals models that mimic SARS may further aid in vaccine design and evaluation.</div></front></TEI><affiliations><list><country><li>États-Unis</li></country><region><li>Ohio</li></region></list><tree><country name="États-Unis"><region name="Ohio"><name sortKey="Saif, L J" sort="Saif, L J" uniqKey="Saif L" first="L. J." last="Saif">L. J. Saif</name></region></country></tree></affiliations></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Sante/explor/SrasV1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 005B77 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 005B77 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Sante
|area= SrasV1
|flux= Main
|étape= Exploration
|type= RBID
|clé= Pascal:05-0154089
|texte= Animal coronavirus vaccines : Lessons for SARS
}}
| This area was generated with Dilib version V0.6.33. |  |